Arezoo Hosseini

1.2k total citations
28 papers, 935 citations indexed

About

Arezoo Hosseini is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Arezoo Hosseini has authored 28 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Arezoo Hosseini's work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Arezoo Hosseini is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Arezoo Hosseini collaborates with scholars based in Iran, Sweden and Australia. Arezoo Hosseini's co-authors include Tohid Gharibi, Behzad Baradaran, Zohreh Babaloo, Faroogh Marofi, Vida Hashemi, Meghdad Abdollahpour‐Alitappeh, Saber Gholizadeh, Sanam Dolati, Mehdi Yousefi and Navid Shomali and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Life Sciences.

In The Last Decade

Arezoo Hosseini

28 papers receiving 928 citations

Peers

Arezoo Hosseini
Zhenyuan Dong United States
Fen Ning China
Zhongjun Dong China
Maryam Hemmatzadeh Iran
A. Möller Germany
Alex Abel United States
Mahmoud Goodarzi United States
Mahdi Shabani Iran
Zhenyuan Dong United States
Arezoo Hosseini
Citations per year, relative to Arezoo Hosseini Arezoo Hosseini (= 1×) peers Zhenyuan Dong

Countries citing papers authored by Arezoo Hosseini

Since Specialization
Citations

This map shows the geographic impact of Arezoo Hosseini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arezoo Hosseini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arezoo Hosseini more than expected).

Fields of papers citing papers by Arezoo Hosseini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arezoo Hosseini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arezoo Hosseini. The network helps show where Arezoo Hosseini may publish in the future.

Co-authorship network of co-authors of Arezoo Hosseini

This figure shows the co-authorship network connecting the top 25 collaborators of Arezoo Hosseini. A scholar is included among the top collaborators of Arezoo Hosseini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arezoo Hosseini. Arezoo Hosseini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hosseini, Arezoo, et al.. (2024). Chemokines in neurodegenerative diseases. Immunology and Cell Biology. 103(3). 275–292. 7 indexed citations
3.
Gharibi, Tohid, Arezoo Hosseini, Faroogh Marofi, et al.. (2023). STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance. International Immunopharmacology. 119. 110160–110160. 7 indexed citations
4.
Hosseini, Arezoo, et al.. (2023). Structure of PD1 and its mechanism in the treatment of autoimmune diseases. Cell Biochemistry and Function. 41(7). 726–737. 13 indexed citations
5.
Hosseini, Arezoo, Tohid Gharibi, Abbas Ebrahimi‐Kalan, et al.. (2021). Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS). Life Sciences. 276. 119395–119395. 26 indexed citations
6.
Hosseini, Arezoo, Navid Shomali, Mahmoud Mansouri, et al.. (2021). miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4. International Immunopharmacology. 92. 107355–107355. 42 indexed citations
7.
Hosseini, Arezoo, Zohreh Babaloo, Tohid Gharibi, et al.. (2020). Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease. BMC Research Notes. 13(1). 568–568. 12 indexed citations
8.
Hosseini, Arezoo, Tohid Gharibi, Faroogh Marofi, Zohreh Babaloo, & Behzad Baradaran. (2020). CTLA-4: From mechanism to autoimmune therapy. International Immunopharmacology. 80. 106221–106221. 203 indexed citations
9.
Hosseini, Arezoo, Vida Hashemi, Navid Shomali, et al.. (2020). Innate and adaptive immune responses against coronavirus. Biomedicine & Pharmacotherapy. 132. 110859–110859. 113 indexed citations
10.
Gharibi, Tohid, Zohreh Babaloo, Arezoo Hosseini, et al.. (2020). Targeting STAT3 in cancer and autoimmune diseases. European Journal of Pharmacology. 878. 173107–173107. 86 indexed citations
11.
Gharibi, Tohid, Zohreh Babaloo, Arezoo Hosseini, et al.. (2020). The role of B cells in the immunopathogenesis of multiple sclerosis. Immunology. 160(4). 325–335. 29 indexed citations
12.
Gharibi, Tohid, Arezoo Hosseini, Faroogh Marofi, et al.. (2019). IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression. Immunology Letters. 216. 12–20. 29 indexed citations
13.
Hashemi, Vida, Amir Salek Farrokhi, Asghar Tanomand, et al.. (2018). Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunology Letters. 204. 16–22. 26 indexed citations
14.
Hosseini, Arezoo, Ali Masjedi, Behzad Baradaran, et al.. (2018). Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis. Journal of Cellular Physiology. 234(7). 9943–9955. 37 indexed citations
15.
Hosseini, Arezoo, et al.. (2018). Curcumin modulates the angiogenic potential of human endothelial cells via FAK/P-38 MAPK signaling pathway. Gene. 688. 7–12. 19 indexed citations
16.
Hashemi, Vida, Sanam Dolati, Arezoo Hosseini, et al.. (2017). Natural killer T cells in Preeclampsia: An updated review. Biomedicine & Pharmacotherapy. 95. 412–418. 36 indexed citations
17.
Hosseini, Arezoo, et al.. (2017). Environmental risk factors for the incidence of cutaneous leishmaniasis in an endemic area of Iran: A GIS-based approach. Spatial and Spatio-temporal Epidemiology. 21. 57–66. 36 indexed citations
18.
Hosseini, Arezoo, et al.. (2016). Prevalence of extended-spectrum ß-lactamase-producing Escherichia coli in agricultural fields of Gorgan district using bovine manure. 6(2). 687–692. 2 indexed citations
19.
Gholizadeh, Saber, H. Ladonni, Habib Mohammadzadeh, et al.. (2015). The Anopheles stephensi odorant binding protein 1 (AsteObp1) gene: A new molecular marker for biological forms diagnosis. Acta Tropica. 146. 101–113. 22 indexed citations
20.
Hosseini, Arezoo, et al.. (2014). Estrogen Receptor Alpha Gene Expression in Breast Cancer Tissues from the Iranian Population - a Pilot Study. Asian Pacific Journal of Cancer Prevention. 15(20). 8789–8791. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenyuan Dong Breakdown of academic impact, for papers by Fen Ning Breakdown of academic impact, for papers by Zhongjun Dong Breakdown of academic impact, for papers by Maryam Hemmatzadeh Breakdown of academic impact, for papers by A. Möller Breakdown of academic impact, for papers by Alex Abel Breakdown of academic impact, for papers by Mahmoud Goodarzi Breakdown of academic impact, for papers by Mahdi Shabani
Rankless by CCL
2026